JPH062659B2 - Skin cosmetics - Google Patents

Skin cosmetics

Info

Publication number
JPH062659B2
JPH062659B2 JP26319185A JP26319185A JPH062659B2 JP H062659 B2 JPH062659 B2 JP H062659B2 JP 26319185 A JP26319185 A JP 26319185A JP 26319185 A JP26319185 A JP 26319185A JP H062659 B2 JPH062659 B2 JP H062659B2
Authority
JP
Japan
Prior art keywords
skin
test
effect
blood flow
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP26319185A
Other languages
Japanese (ja)
Other versions
JPS62123106A (en
Inventor
邦雄 三村
侑 澤島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP26319185A priority Critical patent/JPH062659B2/en
Publication of JPS62123106A publication Critical patent/JPS62123106A/en
Publication of JPH062659B2 publication Critical patent/JPH062659B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • A61K8/675Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】 (技術分野) 本発明は、ニセリトロールを配合してなる皮膚化粧料に
関し、詳しくは、皮膚の血行を持続的に促進し皮膚組織
を賦活すると共に、皮膚の水分保持機能を亢進して、美
肌効果を呈する皮膚化粧料に関する。
Description: TECHNICAL FIELD The present invention relates to a skin cosmetic composition containing niceritrol, and more specifically, it continuously promotes blood circulation in the skin to activate skin tissue and retain water in the skin. The present invention relates to a skin cosmetic which enhances the function and exhibits a beautiful skin effect.

(従来技術) 従来より、健常な美しい皮膚を保持する為に、皮膚に適
度な水分と油分を与える親水性の皮膚保湿剤と油性の皮
膚柔軟剤を皮膚化粧料に配合することが行われている。
(Prior Art) Conventionally, in order to maintain a healthy and beautiful skin, it has been performed to blend a skin moisturizer with a hydrophilic skin moisturizer and an oily skin softener that give appropriate water and oil content to the skin cosmetics. There is.

皮膚保湿剤には、グリセリン、プロピレングリコール、
ポリエチレングリコール、ピロリドンカルボン酸塩等が
利用されているが、これらは、皮膚の最外層である角質
層の水分を吸水して、かえって皮膚の水分を損失する原
因となることがあり、また、多量に含有する皮膚化粧料
にあっては、べたつくなどの異和感を与えるなど、必ず
しも満足出来るものではなかった。
Skin moisturizers include glycerin, propylene glycol,
Polyethylene glycol, pyrrolidone carboxylate, etc. are used, but these may absorb water in the stratum corneum, which is the outermost layer of the skin, and may cause loss of skin water. The skin cosmetics contained in (1) were not always satisfactory, such as giving a strange feeling such as stickiness.

また、皮膚柔軟剤には、流動パラフィン、ワセリン、オ
リーブ油、スクアラン、ラノリン、合成エステル油等が
利用されているが、これらも、表皮よりの水分蒸散を充
分に防ぐ程度に皮膚化粧料に含有せしめるときには、皮
膚の正常なる新陳代謝を阻害する原因となるなどの欠点
を有していた (発明の開示) 本発明者等は、皮膚保湿剤、皮膚柔軟剤にみられる上記
の欠点に鑑み、それらは配合剤の物理的作用による表皮
への水分補給あるいは表皮よりの水分蒸散防止のみに依
存するのではなく、皮膚組織を賦活して皮膚が本来備え
ている水分保持機能を持続的に亢進することによって皮
膚を健常な状態に保持し、あるいは修復するような皮膚
化粧料を提供することを目的として鋭意研究した結果、
ニコチン酸の誘導体であるニセリトロールを配合してな
る皮膚化粧料が該目的に合致する効果を発現し、更に
は、皮膚に湿潤性(しっとり感)、柔軟製(滑らか
感)、弾力性及び艶を与える美肌効果を有することを見
出して本発明を完成するに至った。
Liquid paraffin, petrolatum, olive oil, squalane, lanolin, synthetic ester oil, etc. are used as skin softeners, but these should also be contained in skin cosmetics to the extent that they prevent water evaporation from the epidermis sufficiently. Occasionally, it had drawbacks such as inhibiting normal metabolism of the skin (disclosure of the invention). In view of the above-mentioned drawbacks found in skin moisturizers and skin softeners, the By not only relying on the hydration of the epidermis by the physical action of the compounding agent or the prevention of water evaporation from the epidermis, by activating the skin tissue and continuously enhancing the water retention function originally possessed by the skin As a result of earnest research for the purpose of providing a skin cosmetic that maintains or restores the skin in a healthy state,
A skin cosmetic prepared by incorporating niceritrol, which is a derivative of nicotinic acid, exhibits an effect that meets the purpose, and further, has a wettability (moist feeling), softness (smooth feeling), elasticity and gloss. The present invention has been completed by finding that it has a skin-beautifying effect of giving

(発明の目的) 本発明の目的は、皮膚の水分保持機能(荒肌改善効果、
角質改善効果、保湿効果)と美肌効果等の優れた皮膚化
粧料を提供するにある。
(Object of the Invention) The object of the present invention is to retain the water content of the skin (effect of improving rough skin,
It is intended to provide a skin cosmetic excellent in keratin improving effect, moisturizing effect) and beautiful skin effect.

(発明の構成) 本発明は、ニセリトロールを配合してなる皮膚化粧料で
ある。
(Structure of the Invention) The present invention is a skin cosmetic material containing niceritrol.

(構成の具体的な説明) 本発明に用いるニセリトロールは公知の物質であって、
優れた血清脂低下作用を有する薬剤として高脂質血症の
改善に適用されている。
(Specific Description of Structure) Niceritrol used in the present invention is a known substance,
It has been applied to improve hyperlipidemia as a drug having an excellent serum lipid lowering action.

ニセリトロールに関する化学的性質等は下記の通りであ
る。
The chemical properties and the like of niceritrol are as follows.

(1) 構造 (2) 化学名:四ニコチン酸ペンタエリスリトール (Pentaerythritol tetranicotinate) (3) 分子式:C29H24N4O8 (4) 分子量:556.54 (5) 融 点:162〜165℃ 本発明の皮膚化粧料に配合せるニセリトロールは、皮膚
内に吸収された後、エステラーゼの作用により徐々に遊
離のニコチン酸を生成するものであって、皮膚刺激も無
く持続的な血行促進作用を発現するものであると推察さ
れる。
(1) Structure (2) Chemical name: Pentaerythritol tetranicotinate (3) Molecular formula: C 29 H 24 N 4 O 8 (4) Molecular weight: 556.54 (5) Melting point: 162-165 ° C. Skin cosmetics of the present invention After being absorbed into the skin, niceritrol, which is to be blended with, gradually produces free nicotinic acid by the action of esterase, and expresses a continuous blood circulation promoting action without skin irritation. Inferred.

ニセリトロールの配合量は、皮膚化粧料(組成物)の総
量を基準として0.05〜1.0wt%の範囲が好適である。配
合量が0.05wt%未満では効果が充分に達成されず、一方
1.0wt%を超えてもその増加分に見合った効果の向上は
望めない。
The blending amount of niceritrol is preferably in the range of 0.05 to 1.0 wt% based on the total amount of the skin cosmetic (composition). If the blending amount is less than 0.05 wt%, the effect is not sufficiently achieved, while
Even if it exceeds 1.0 wt%, the improvement of the effect commensurate with the increase cannot be expected.

本発明の皮膚化粧料は、例えばローション類、乳液類、
クリーム類、パック類等に適用することができる。
The skin cosmetics of the present invention include, for example, lotions, emulsions,
It can be applied to creams, packs and the like.

尚、本発明の皮膚化粧料には上記の他に色素、香料、防
腐剤、界面活性剤、顔料、抗酸化剤等を本発明の目的を
達成する範囲内で適宜配合することができる。
In addition to the above, a colorant, a fragrance, an antiseptic, a surfactant, a pigment, an antioxidant and the like can be appropriately added to the skin cosmetic of the present invention within the range where the object of the present invention is achieved.

(実施例) 以下、実施例及び比較列に基づいて本発明を詳説する。(Examples) Hereinafter, the present invention will be described in detail based on examples and comparative columns.

尚、皮膚血流量試験法、保湿効果試験法、荒れ肌改善効
果試験法、角質改善効果試験法、官能テスト(美肌効果
試験法)は下記の通りである。
The skin blood flow rate test method, the moisturizing effect test method, the rough skin improving effect test method, the keratin improving effect test method, and the sensory test (beautiful skin effect test method) are as follows.

(1) 皮膚血流量試験法 ニュージーランドホワイト系家兎3羽の腹部を刈毛し、
18時間絶食させた後、ペンタバルビトールのナトリウ
ム塩を35mg/kgの割合で静脈注射し麻酔処置する。プ
レートタイプトランスジューサーを腹部の試料塗布部位
(試験部位)上にセロファンテープで固定し、交叉熱電
堆式皮膚血流計(シンエイ社製シンコーダー、201
型)を用いて皮膚血流量(μV)を測定する。
(1) Skin blood flow test method 3 New Zealand White rabbits were shaved on the abdomen,
After being fasted for 18 hours, pentabarbitol sodium salt is intravenously injected at a rate of 35 mg / kg for anesthesia. A plate-type transducer was fixed on the sample application site (test site) on the abdomen with cellophane tape, and a cross thermoelectric skin blood flow meter (Shin-Ai Co., Ltd., 201
Skin blood flow (μV) is measured using a (type).

試料は3×2cmの皮膚部位に対して0.1gを均一に塗布
し、試料塗布前の血流量(C)と試料塗布後一定時間
後(例えば0.5、1.0、2.0時間後)の血流量(Ct)を
測定し、下記の式により血流量増加率(%)を算出す
る。
Blood flow sample was uniformly applied to 0.1g to the skin site of 3 × 2 cm, and a predetermined time after the sample application blood flow before sample application (C B) (e.g. 0.5, 1.0, 2.0 hours later) ( Ct) is measured, and the blood flow increase rate (%) is calculated by the following formula.

試験結果は3羽の血流量増加率の平均値で示した。The test results are shown by the average value of the blood flow increase rate of 3 birds.

血流量の増加は、皮膚化粧料のクリーム基剤を試料とし
て塗布した場合でも5〜20%程度の増加率が認められ
るが、血行促進作用の顕著な成分を配合した試料を塗布
したときは、40〜80%のごとく増加率は高くなる。
The increase in blood flow is found to be about 5 to 20% even when the cream base for skin cosmetics is applied as a sample, but when a sample containing a component with a remarkable blood circulation promoting effect is applied, The rate of increase is as high as 40 to 80%.

(2) 荒肌改善効果試験法 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。被験者の左側下脚試験部
位に1日1回約1gの試料を塗布し、試験開始前および
終了後の皮膚の状態を下記の判定基準により判定した。
右側下脚は試料を塗布せず対照とした。
(2) Rough skin improving effect test method 20 middle-aged and elderly subjects having rough skin on the lower legs were tested for the effect of continuous application for 4 weeks. Approximately 1 g of the sample was applied to the left lower leg test site of the test subject once a day, and the condition of the skin before and after the start of the test was evaluated according to the following criteria.
The lower right leg was not coated with the sample and served as a control.

皮膚乾燥度の判定基準 − :正常 ± :軽微乾燥、落屑無し + :乾燥、落屑軽度 ++ :乾燥、落屑中等度 +++:乾燥、落屑顕著 試験前後の試験部位と対象部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−、
++→±)を有効、1段階改善された場合をやや有効、
変化がなかった場合を無効とした。試験結果は有効、や
や有効となった被験者の人数で示した。
Criteria for skin dryness −: Normal ±: Minor dryness, no desquamation +: Dryness, mild desquamation ++: Dryness, moderate desquamation +++: Dryness, desquamation prominent Compare the judgment results of the test site before and after the test, When skin dryness is improved by two or more stages (for example, + →-,
++ → ±) is valid, and if it is improved by one step, it is somewhat valid,
When there was no change, it was invalidated. The test results were shown by the number of subjects who were valid or slightly valid.

(3) 角質改善(角質細胞の抗剥離性増大)効果試験法 前述の荒れ肌改善測定試験開示前および終了後の被験部
皮膚にスコッチテープ(ニチバンメンディングテープ)
を接着し、これを剥離した時テープに付着した角質細胞
の状態を走査型電子顕微鏡によって詳細に調べ、下記の
基準によって皮膚角質細胞抗剥離性を解析し、角質改善
効果を求めた。角質改善効果(角質細胞抗剥離性増大)
の判定基準 評価点1 スケールを認めず 2 小スケール点在 3 小〜中スケール顕著 4 大スケール顕著 評価は4週間連続塗布後の試験部位の評価点と対照部位
のそれとの差が2点以上の場合を有効、1点の場合をや
や有効、0点の場合を無効とした。判定結果は有効、や
や有効となった被験者の人数で示した。
(3) Keratin improvement (increased keratinocyte anti-exfoliation) effect test method Scotch tape (Nichiban Mending Tape) on the skin of the test area before and after the disclosure of the rough skin improvement measurement test described above
Was adhered, and the state of keratinocytes attached to the tape when peeled off was examined in detail with a scanning electron microscope, and the skin keratinocyte anti-peeling property was analyzed according to the following criteria, and the keratin improving effect was obtained. Keratin improving effect (increased keratinocyte anti-exfoliation)
Judgment criteria Evaluation score 1 No scale is recognized 2 Small scale is scattered 3 Small to medium scale is significant 4 Large scale is significant Evaluation is that the difference between the evaluation score of the test site after continuous application for 4 weeks and that of the control site is 2 or more. The case was set as valid, the case of 1 point was set as slightly valid, and the case of 0 point was set as invalid. The judgment results are shown by the number of subjects who were valid and slightly valid.

(4) 保湿効果試験法 前記荒肌改善効果試験の開始前及び終了後、各被験者の
試験部位の皮膚コンダクタンス値(単位はマイクロモ
ー)を、インピーダンスメーター(I.B.S社製、IBS
−354型)を用いて測定した。
(4) Moisturizing effect test method Before and after the start of the rough skin improving effect test, the skin conductance value (unit: micromho) of the test site of each subject was measured by an impedance meter (IBS, IBS).
-354 type).

皮膚コンダクタンス値が大きい程一般に皮膚の電気抵抗
が小さく、皮膚の角質水分含量が多いことが認められて
いる。
It is generally recognized that the higher the skin conductance value, the lower the electric resistance of the skin and the higher the keratin water content of the skin.

保湿効果は、下記の式で求められる角質水分増加率
(%)より評価した。
The moisturizing effect was evaluated from the rate of increase in keratin water content (%) calculated by the following formula.

:試料塗布部位の試験開始前のコンダクタンス
値 W :試料塗布部位の試験終了時のコンダクタンス
値 試験結果は被験者20名の角質水分増加率の平均値で示
した。
W 0 : Conductance value of the sample application site before the start of the test W: Conductance value of the sample application site at the end of the test The test results are shown as the average value of the keratin water increase rate of 20 test subjects.

(5) 官能テスト(美肌効果試験) 荒れ肌、小じわ、乾燥肌等を訴える女子被験者(35〜
55才)20人に試料を1日2回(朝夕)連続3ケ月塗
布して3ケ月後の効果を評価した。試験結果は、皮膚の
湿潤性、平滑性、弾力性の各項目に対して、皮膚に潤い
が生じた、皮膚が滑らかになった、皮膚に張りが生じた
と回答した人数で示した。
(5) Sensory test (Beautiful skin effect test) Female subjects who complain of rough skin, fine wrinkles, dry skin (35-35)
The sample was applied to 20 people (55 years old) twice a day (morning and evening) for 3 consecutive months, and the effect after 3 months was evaluated. The test results are shown by the number of people who responded that moisturized skin, smoothed skin, and tense skin were generated for each item of wettability, smoothness, and elasticity of the skin.

実施例1〜4、比較例1〜4 〔二層型スキンローション〕 下記の組成のごとく二層型スキンローション基剤にニコ
チン酸及びその誘導体を第1に記載の通りに配合して各
々のスキンローションを調製し、前記諸試験を実施し
た。
Examples 1 to 4 and Comparative Examples 1 to 4 [Two-layer skin lotion] Each skin was prepared by blending a two-layer skin lotion base with nicotinic acid and a derivative thereof as described in the first embodiment. A lotion was prepared and the above tests were carried out.

尚、皮膚血流試験では試料塗布後、0.5、1.0、2.0時間
後の各々の血流量増加率を測定した。
In the skin blood flow test, the rate of increase in blood flow was measured 0.5, 1.0, and 2.0 hours after application of the sample.

(1) 組成 (2) 調製法 (A)、(B)成分を各々均一に溶解した後、(A)成分と(B)成
分を混合攪拌分散し、次いで容器に充填する。使用時に
は内容物を均一に振盪分散して使用する。
(1) Composition (2) Preparation method After the components (A) and (B) are uniformly dissolved, the component (A) and the component (B) are mixed with stirring and dispersed, and then filled in a container. At the time of use, the contents should be evenly dispersed by shaking.

(3) 特性 各二層型スキンローションの諸試験を実施した結果を第
1表右欄に記載した。
(3) Properties The results of various tests of each two-layer type skin lotion are shown in the right column of Table 1.

第1表に示すごとく、比較例1〜4のスキンローション
の基剤及び従来より知られているニコチン酸、ニコチン
酸メチル、ニコチン酸アミドを配合したものは、血流量
増加率が低いかまたは時間を経るに従って血流量増加率
低減するものであった。また、比較例2,3には皮膚刺
激があり、ヒト皮膚での試験は不可能であった。
As shown in Table 1, those containing the bases of the skin lotions of Comparative Examples 1 to 4 and the conventionally known nicotinic acid, methyl nicotinate, and nicotinic acid amide have a low blood flow increase rate or time. The blood flow rate of increase was decreased with the passage of time. Further, Comparative Examples 2 and 3 had skin irritation, and the test on human skin was impossible.

実施例1〜4の本発明の皮膚化粧料は諸試験の総てに亘
って明らかに良好な結果を示した。
The skin cosmetics of the present invention of Examples 1 to 4 clearly showed good results in all tests.

尚、実施例1〜4はヒト皮膚での諸試験に於いて皮膚刺
激は生じなかった。
In Examples 1 to 4, skin irritation did not occur in various tests on human skin.

実施例5〜7、比較例5〜7 〔スキンクリーム〕 実施例1と同様に、下記の組成にて各々のスキンクリー
ムを調製し、諸試験を実施した結果を第1表右欄に示し
た。
Examples 5-7, Comparative Examples 5-7 [Skin cream] Similar to Example 1, each skin cream was prepared with the following composition, and various tests were carried out. The results are shown in the right column of Table 1. .

(1) 組成 (2) 調製法 (A)成分及び(B)成分を各々80℃に加熱溶解した後、混
合して、攪拌しつつ30℃迄冷却して各スキンクリーム
を調製した。
(1) Composition (2) Preparation Method Each of the components (A) and (B) was heated and dissolved at 80 ° C, mixed, and cooled to 30 ° C with stirring to prepare each skin cream.

(3) 特性 第1表に示すごとく、本発明の皮膚化粧料である実施例
5〜7のスキンクリームは、比較例5〜7と比較して持
続的な血流量増加率を示すと共に諸試験において優れた
効果を示し、ニセリトロールの配合量は0.05〜1.0wt%
の範囲で本発明の目的を達成し得るものである。
(3) Properties As shown in Table 1, the skin creams of Examples 5 to 7, which are the skin cosmetics of the present invention, show a continuous increase rate of blood flow and various tests as compared with Comparative Examples 5 to 7. The excellent effect is shown, and the compounding amount of niceritrol is 0.05 ~ 1.0wt%
Within the range, the object of the present invention can be achieved.

(発明の効果) 以上記載のごとく、本発明は、皮膚の水分保持機能(荒
肌改善効果、角質改善効果、保湿効果)と美肌効果(官
能テスト)等に優れると共に、皮膚刺激性の低い皮膚化
粧料を提供することは明らかである。
(Effects of the Invention) As described above, the present invention is excellent in skin water retention function (rough skin improving effect, keratin improving effect, moisturizing effect) and beautiful skin effect (sensory test), and also has low skin irritation. It is clear to provide cosmetics.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】ニセリトロールを配合してなる皮膚化粧
料。
1. A skin cosmetic composition containing niceritrol.
JP26319185A 1985-11-22 1985-11-22 Skin cosmetics Expired - Lifetime JPH062659B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26319185A JPH062659B2 (en) 1985-11-22 1985-11-22 Skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26319185A JPH062659B2 (en) 1985-11-22 1985-11-22 Skin cosmetics

Publications (2)

Publication Number Publication Date
JPS62123106A JPS62123106A (en) 1987-06-04
JPH062659B2 true JPH062659B2 (en) 1994-01-12

Family

ID=17386033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26319185A Expired - Lifetime JPH062659B2 (en) 1985-11-22 1985-11-22 Skin cosmetics

Country Status (1)

Country Link
JP (1) JPH062659B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3000699A (en) * 1998-03-16 1999-10-11 Procter & Gamble Company, The Skin moisturizing compositions

Also Published As

Publication number Publication date
JPS62123106A (en) 1987-06-04

Similar Documents

Publication Publication Date Title
JPH026321B2 (en)
US6210692B1 (en) Emulsion comprising a hydrophilic thickening compound and a polysaccharide alkyl ether, compositions and products comprising the emulsion, and uses thereof
JPS62292710A (en) Skin cosmetic
JPH0662385B2 (en) Emulsified composition
JP3426436B2 (en) Skin cosmetics
JP2549119B2 (en) Topical
JPH06104620B2 (en) Skin cosmetics
JP2005289995A (en) Oil/water type cosmetic composition manufactured using polyglyceryl-3-methylglucose distearate
JPH0696514B2 (en) Skin cosmetics
JPS6231975B2 (en)
JPH062659B2 (en) Skin cosmetics
JP2001278768A (en) Skin care preparation
JPH0692290B2 (en) Skin cosmetics
JP3220294B2 (en) Skin protection composition
JPH0429919A (en) Moisture-retaining cosmetic
JPS62126106A (en) Skin cosmetic
JPS6241684B2 (en)
JPH062660B2 (en) Skin cosmetics
JP3532713B2 (en) Skin cosmetics
JPS62153206A (en) Skin cosmetic
JPH07309710A (en) External base
JPS62123105A (en) Skin cosmetic
JPS62138410A (en) Skin cosmetic
JP2925266B2 (en) Skin cosmetics
JPH10139687A (en) Skin preparation for external use